Facts
Drug companies have experts on their payroll who are part of the FDA's drug safety decision panels, and who don't disclose their conflicts of interest. They are making decisions that expand the definition of disease. A classic case of this was when cholesterol numbers were lowered from 130 to 100 to instantly make 10 million more Americans diagnosable with high cholesterol so they could be treated with statin drugs.